logo
Select company
Select metric
$ -6.81MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
28
Sector
66
Industry
33
History
40
$ 0.53Close
$ 0.43 - $ 1.33 52-Week Range
Ticker Information

Ticker

MLSS

Company Name

MILESTONE SCIENTIFIC INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NYSEMKT

MILESTONE SCIENTIFIC INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MLSS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 163.46K$ -6.97M$ -6.81M
3/31/2025$ 144.01K$ -5.29M$ -5.14M
12/31/2024$ 134.84K$ -4.71M$ -4.58M
9/30/2024$ 132.79K$ -4.76M$ -4.63M
6/30/2024$ 138.91K$ -4.77M$ -4.63M
3/31/2024$ 147.12K$ -7.23M$ -7.09M
12/31/2023$ 150.77K$ -7.05M$ -6.9M
9/30/2023$ 153.42K$ -7.06M$ -6.91M
6/30/2023$ 225.63K$ -7.6M$ -7.37M
3/31/2023$ 184.74K$ -8.19M$ -8.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MILESTONE SCIENTIFIC INC's latest trailing twelve months (TTM) EBITDA stands at $ -8.98M.
  • Over the past 5 years, MILESTONE SCIENTIFIC INC's average EBITDA has been $ -6.82M.
  • The median EBITDA for MILESTONE SCIENTIFIC INC during this period was $ -6.91M
  • MILESTONE SCIENTIFIC INC reached its highest EBITDA over the past 5 years at $ -4.58M.
  • The lowest EBITDA recorded by MILESTONE SCIENTIFIC INC in the same timeframe $ -8.98M

MILESTONE SCIENTIFIC INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP $ -4.97MNXGL : NEXGEL INC $ -2.29MVERU : VERU INC $ -31.9MCUE : CUE BIOPHARMA INC $ -36.06MFEMY : FEMASYS INC $ -18.34MNEPH : NEPHROS INC $ 1.49MPSTV : PLUS THERAPEUTICS INC $ -14.57MOVID : OVID THERAPEUTICS INC $ -36.47MBCAB : BIOATLA INC $ -58.76MALGS : ALIGOS THERAPEUTICS INC $ -58.76M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for MILESTONE SCIENTIFIC INC is calculated as follows: EBIT [ $ -9.1M ] + DepAmor [ $ 114.45K ]
(=) EBITDA [ $ -8.98M ]

MLSS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -8.98M

Minimum

Sep 30, 2020

$ -4.58M

Maximum

Dec 31, 2024

$ -6.82M

Average

$ -6.91M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M